Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by blackjackallon Dec 30, 2016 10:54am

150 Views

Post# 25653465

RE:Surprised This Didn't Drop To a Dime

Too bad you don't know how to read an MD&A. They had cashflow of $387k in Q4 and that's after spending over $250k in finishing Lumisort development. I'd say Q4 was a nice success but if you want to mislead people by twisting facts you go right ahead. I'll correct you as you go, no charge.

Bullboard Posts

Calibre discovers significant gold in Newfoundland